Story by Zeke Gonzalez | Walter Reed Army Institute of Research | 05.29.2025
The Kombewa Clinical Research Center celebrated its 27th anniversary on 10 March, 2025 in Kombewa, Kenya. During the event, staff recognized the Center’s 27 years of contributions to protecting the warfighter and the public from medical threats. Founded in 1998 as a research site, the Kombewa Clinical Research Center was started as a Walter Reed Army Institute of Research-Africa and Kenya......
Story by Zeke Gonzalez | Walter Reed Army Institute of Research | 04.17.2025
On March 14, 2025, researchers from the Walter Reed Army Institute of Research met with Dr. Irene Soares, an associate professor at the University of São Paulo, to discuss a possible collaboration on “Vivaxin”, a candidate vaccine against Plasmodium vivax malaria. “Vivaxin” targets the malaria caused by the parasite Plasmodium vivax, a vaccine WRAIR is uniquely positioned to support......
Story by Maj. Jessica Tait | U.S. Africa Command | 08.11.2023
U.S. Naval Forces Europe-Africa (NAVEUR-NAVAF) Force Surgeon held an operational entomology event in support of the Africa Malaria Task Force (AMTF), July 17-21, in Accra, Ghana....
Story by Lori Newman | Brooke Army Medical Center Public Affairs | 06.30.2023
Mosquitos aren’t just pesky insects that bite, they can spread some serious diseases such as Zika virus, West Nile virus, Chikungunya virus, dengue, and malaria....
Story by Robert Hammer | Defense Health Agency | 06.22.2023
Countermeasures for vector-borne diseases are often offered in the military when a service member is deployed to certain parts of the world. These types of countermeasures were developed to protect from infections spread by insects, rodents, and other animals. Insect-borne diseases, such as yellow fever, tick-borne encephalitis, Japanese encephalitis, and others infect millions of people each......
Story by Lee Osberry | Walter Reed Army Institute of Research | 09.13.2022
Researchers from the Walter Reed Army Institute of Research (WRAIR) report the malaria vaccine FMP013 antigen and ALFQ adjuvant combination appears safe and immunogenic for adults in the first-in-human evaluation results published in the Vaccine journal. Although malaria control efforts yielded steady progress over the past decade, instability introduced by the COVID-19 pandemic has resulted......
Courtesy Story | Walter Reed Army Institute of Research | 06.23.2022
WRAIR and Partners Develop Nigeria’s First-Ever Malaria Slide Bank
Story by Carey Phillips | Medical Research and Development Command | 08.16.2021
By Jeffrey Soares, USAMMDA public affairs Recently, the U.S. Army Medical Materiel Development Activity’s Warfighter Protection and Acute Care Project Management Office, along with its commercial partner BioFire Defense, announced the U.S. Food and Drug Administration had granted marketing approval for the Global Fever Panel, which is used to analyze specimens of human blood for the......
